Cargando…

Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE Study

INTRODUCTION: Approval of sunitinib and everolimus for the treatment of progressive, unresectable or metastatic well-differentiated pancreatic neuroendocrine tumors (pNETs) was obtained in France in 2011 and 2012, respectively. OPALINE was set up as an observational study to evaluate the efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Denis, Lepage, Côme, Vicaut, Eric, Dominguez, Sophie, Coriat, Romain, Dubreuil, Olivier, Lecomte, Thierry, Baudin, Eric, Venat Bouvet, Laurence, Samalin, Emmanuelle, Santos, Alexandre, Borie, Odile, Bisot-Locard, Ségolène, Goichot, Bernard, Lombard-Bohas, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123044/
https://www.ncbi.nlm.nih.gov/pubmed/35419649
http://dx.doi.org/10.1007/s12325-022-02103-7